FDA approves Exelon to treat dementia of Parkinson’s disease
• Drug News • Jun 28, 2006
The Food and Drug Administration (FDA) has approved Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia (chronic loss or impairment of intellectual capacity) associated with Parkinson’s .......
Exelon is manufactured by Novartis Pharmaceutical Corp. in East Hanover, NY.
Parkinson's disease dementia. Exelon, the first drug indicated for this condition, has previously been approved as a therapeutic for Alzheimer's disease.
"It's been recognized for almost a decade that the dementia of patients with Parkinson's disease differs from the dementia of patients with Alzheimer's," said Dr. Steven Galson, Director of FDA's Center for Drug Evaluation and Research, "but until now, there has been no treatment that has been shown to be effective specifically for the dementia associated with Parkinson's Disease. Today's approval of Exelon helps to fill this medical need."
Exelon is a choline esterase inhibitor, which works by increasing the levels on acetylcholine in the brain. It has already secured marketing authorization in Europe and according to a Forbes news report, has already been approved to treat Parkinson's Disease dementia in 14 other countries.
which is it - they don't actually know?? or are they lying??
AFX News Limited
Novartis' Exelon cleared by US FDA for Parkinson's disease dementia
06.28.2006, 02:04 AM
Patients treated with Exelon also had less deterioration in their ability to perform activities of daily living than patients who received placebo. Patients enrolled in the study had mild to moderately severe dementia, which developed at least two years after they were diagnosed with Parkinson's disease.
dementia after two years????? do alzheimers progress that fast because we don't.......open your eyes here please.....this is bull****
Exelon was granted European marketing authorization for this indication in March 2006. It has also been approved to treat Parkinson's disease dementia in 14 other countries around the world.
why?
http://www.forbes.com/feeds/afx/2006...fx2845132.html
I'm just getting started.